Colossal Biosciences, the world’s first de-extinction company, has announced $200M in a Series C financing by TWG Global, a diversified holding company with operating...
Neomorph, Inc., announced the appointment of Dr. Klaus Wagner as Chief Medical Officer. Dr. Wagner is a seasoned biotech executive with extensive experience in...
Bioptimus, the pioneering AI foundation model company, announced that it has reached a significant funding milestone of $76 million. This total includes a $41...
Revvity, Inc, a global leader in technology solutions, has announced a transformative strategic partnership with Element Biosciences, Inc., a pioneering life sciences company dedicated...
Cytovance Biologics and PolyPeptide have announced a partnership that combines Cytovance’s expertise in microbial and mammalian expression, process development and cGMP manufacturing with PolyPeptide’s capabilities in complex...
